JP2023520883A5 - - Google Patents

Info

Publication number
JP2023520883A5
JP2023520883A5 JP2022560032A JP2022560032A JP2023520883A5 JP 2023520883 A5 JP2023520883 A5 JP 2023520883A5 JP 2022560032 A JP2022560032 A JP 2022560032A JP 2022560032 A JP2022560032 A JP 2022560032A JP 2023520883 A5 JP2023520883 A5 JP 2023520883A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
optionally substituted
bond
substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022560032A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520883A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/022976 external-priority patent/WO2021202114A1/en
Publication of JP2023520883A publication Critical patent/JP2023520883A/ja
Publication of JP2023520883A5 publication Critical patent/JP2023520883A5/ja
Pending legal-status Critical Current

Links

JP2022560032A 2020-03-30 2021-03-18 Rnaウイルス感染症、特にcovid-19を処置するための抗ウイルス化合物および方法 Pending JP2023520883A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063001723P 2020-03-30 2020-03-30
US63/001,723 2020-03-30
US202063053908P 2020-07-20 2020-07-20
US63/053,908 2020-07-20
PCT/US2021/022976 WO2021202114A1 (en) 2020-03-30 2021-03-18 Antiviral compounds and method for treating rna viral infection, particularly covid-19

Publications (2)

Publication Number Publication Date
JP2023520883A JP2023520883A (ja) 2023-05-22
JP2023520883A5 true JP2023520883A5 (https=) 2024-03-25

Family

ID=77920792

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022560032A Pending JP2023520883A (ja) 2020-03-30 2021-03-18 Rnaウイルス感染症、特にcovid-19を処置するための抗ウイルス化合物および方法
JP2022560026A Pending JP2023520882A (ja) 2020-03-30 2021-03-18 肝臓指向性のウイルス感染症、特にb型肝炎およびd型肝炎を処置するための抗ウイルス化合物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022560026A Pending JP2023520882A (ja) 2020-03-30 2021-03-18 肝臓指向性のウイルス感染症、特にb型肝炎およびd型肝炎を処置するための抗ウイルス化合物および方法

Country Status (11)

Country Link
US (2) US20210308137A1 (https=)
EP (2) EP4126846A1 (https=)
JP (2) JP2023520883A (https=)
KR (2) KR20230004550A (https=)
CN (1) CN116075502B (https=)
AU (2) AU2021249224A1 (https=)
BR (2) BR112022019558A2 (https=)
CA (2) CA3179167A1 (https=)
IL (2) IL296927B2 (https=)
TW (2) TW202203914A (https=)
WO (2) WO2021202114A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102641010B1 (ko) 2023-12-04 2024-02-28 대한민국 실미타세르팁을 유효성분으로 포함하는 중증열성혈소판감소증후군 예방 또는 치료용 약학 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0719123A2 (pt) * 2006-09-01 2013-12-17 Cylene Pharmaceuticals Inc Moduladores de serina-treonina proteína cinase e parp
CN101528704B (zh) * 2006-09-01 2014-04-09 生华生物科技股份有限公司 丝氨酸-苏氨酸蛋白激酶和parp调节剂
JP2011515337A (ja) * 2008-02-29 2011-05-19 サイレーン ファーマシューティカルズ, インコーポレイテッド プロテインキナーゼモジュレーター
KR20120044281A (ko) * 2009-04-17 2012-05-07 사일린 파마슈티칼스, 인크 단백질 키나제 ck2 활성과 관련된 장애의 치료 방법
US20110071136A1 (en) * 2009-09-16 2011-03-24 Cylene Pharmaceuticals, Inc Novel tricyclic protein kinase modulators
US8853235B2 (en) * 2009-11-23 2014-10-07 Senhwa Biosciences, Inc. Polymorphs and salts of a kinase inhibitor
JP5802676B2 (ja) * 2009-12-04 2015-10-28 センワ バイオサイエンシズ インコーポレイテッド Ck2阻害剤としてのピラゾロピリミジンおよび関連複素環化合物
TWI534148B (zh) * 2014-02-13 2016-05-21 生華生物科技股份有限公司 吡唑並嘧啶前藥及其使用方法
CN105457029A (zh) * 2014-09-29 2016-04-06 中国科学院上海巴斯德研究所 抑制酪蛋白激酶2活性在促进i型干扰素表达的应用
WO2021195126A1 (en) * 2020-03-24 2021-09-30 Burnet Michael W Anti-infective and anti-viral compounds and compositions
WO2021247367A1 (en) * 2020-06-02 2021-12-09 Yale University Compounds and compositions for treating, ameliorating, and/or preventing sars-cov-2 infection and/or complications thereof

Similar Documents

Publication Publication Date Title
JP2023500611A5 (https=)
JP2021534124A5 (https=)
JP2016509591A5 (https=)
AR065276A1 (es) Herbicidas de n-oxidos de piridina sustituidos
RU2006118326A (ru) Производное циклического амина, содержащее гетероарильный цикл
JP2002536329A5 (https=)
JP2016516043A5 (https=)
RU93058600A (ru) Производные пиперидина, обладающие анксиолитическим действием, фармацевтическая композиция на их основе
JP2006507220A5 (https=)
JP2011507849A5 (https=)
JP2004533444A5 (https=)
JP2003519676A5 (https=)
JP2004535436A5 (https=)
JP2007500734A5 (https=)
JP2016500653A5 (https=)
JP2016508135A5 (https=)
JP2013542267A5 (https=)
RU2394031C2 (ru) Соли четвертичного аммония в качестве антагонистов м3
JP2008545718A5 (https=)
JP2004529953A5 (https=)
JP2023512206A5 (https=)
JP2023520883A5 (https=)
JP2008521908A5 (https=)
JP2023512227A5 (https=)
FR2903405A1 (fr) Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications